This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roguin, A. Articles by Calkins, H. Search for Related Content PubMed PubMed Citation Articles by Roguin, A. Articles by Calkins, H.

Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy

Ariel Roguin, MD, PhD^*, Chandra S. Bomma, MD^*, Khurram Nasir, MD, MPH^*, Harikrishna Tandri, MRCP^*, Crystal Tichnell, MGC^*, Cynthia James, PhD^*, Julie Rutberg, BS^*, Jane Crosson, MD, Philip J. Spevak, MD, FACC, Ronald D. Berger, PhD, MD, FACC^*, Henry R. Halperin, MA, MD^* and Hugh Calkins, MD, FACC^*,*

^* Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
Pediatric Cardiology, Division of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA

View larger version (17K): [in a new window]   Figure 1 Age at time of defibrillator implantation in 42 patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

View larger version (19K): [in a new window]   Figure 2 (A) Interval between implantation of the defibrillator and the first appropriate discharge in 33 patients. (B) Number of appropriate implantable cardioverter-defibrillator (ICD) discharges in 33 patients.

View larger version (26K): [in a new window]   Figure 3 Cumulative rates of first appropriate discharges according to (A) gender and (B) detection of spontaneous ventricular tachycardia (VT) in electrocardiogram, Holter monitoring, or exercise treadmill test. (C) Right ventricular (RV) dilation and (D) induction of VT during electrophysiologic study (EPS).